105 related articles for article (PubMed ID: 15964788)
1. Early stages of salmon calcitonin aggregation: effect induced by ageing and oxidation processes in water and in the presence of model membranes.
Gaudiano MC; Colone M; Bombelli C; Chistolini P; Valvo L; Diociaiuti M
Biochim Biophys Acta; 2005 Jun; 1750(2):134-45. PubMed ID: 15964788
[TBL] [Abstract][Full Text] [Related]
2. Effects induced by hydroxyl radicals on salmon calcitonin: a RP-HPLC, CD and TEM study.
Gaudiano MC; Diociaiuti M; Bertocchi P; Valvo L
Biochim Biophys Acta; 2003 Sep; 1623(1):33-40. PubMed ID: 12957715
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin forms oligomeric pore-like structures in lipid membranes.
Diociaiuti M; Polzi LZ; Valvo L; Malchiodi-Albedi F; Bombelli C; Gaudiano MC
Biophys J; 2006 Sep; 91(6):2275-81. PubMed ID: 16940475
[TBL] [Abstract][Full Text] [Related]
4. Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time.
Kamgar-Parsi K; Hong L; Naito A; Brooks CL; Ramamoorthy A
J Biol Chem; 2017 Sep; 292(36):14963-14976. PubMed ID: 28739873
[TBL] [Abstract][Full Text] [Related]
5. Metal ions as cofactors for aggregation of therapeutic peptide salmon calcitonin.
Rastogi N; Mitra K; Kumar D; Roy R
Inorg Chem; 2012 May; 51(10):5642-50. PubMed ID: 22571374
[TBL] [Abstract][Full Text] [Related]
6. Comparison of reversible and nonreversible aqueous-soluble lipidized conjugates of salmon calcitonin.
Cheng W; Lim LY
Mol Pharm; 2008; 5(4):610-21. PubMed ID: 18481870
[TBL] [Abstract][Full Text] [Related]
7. A role for the C-terminus of calcitonin in aggregation and gel formation: a comparative study of C-terminal fragments of human and salmon calcitonin.
Moriarty DF; Vagts S; Raleigh DP
Biochem Biophys Res Commun; 1998 Apr; 245(2):344-8. PubMed ID: 9571152
[TBL] [Abstract][Full Text] [Related]
8. Effect of lyophilization on liposomal encapsulation of salmon calcitonin.
Swaminathan J; Ehrhardt C
J Liposome Res; 2014 Dec; 24(4):297-303. PubMed ID: 24708057
[TBL] [Abstract][Full Text] [Related]
9. Development of Calcitonin Salmon Nasal Spray: similarity of peptide formulated in chlorobutanol compared to benzalkonium chloride as preservative.
Costantino HR; Culley H; Chen L; Morris D; Houston M; Roth S; Phoenix MJ; Foerder C; Philo JS; Arakawa T; Eidenschink L; Andersen NH; Brandt G; Quay SC
J Pharm Sci; 2009 Oct; 98(10):3691-706. PubMed ID: 19226627
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin-induced changes in the organization of sulfatide-containing membranes.
Viani P; Cervato G; Gatti P; Cestaro B
Biochim Biophys Acta; 1992 Apr; 1106(1):77-84. PubMed ID: 1581336
[TBL] [Abstract][Full Text] [Related]
11. Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrils.
Onoue S; Ohshima K; Debari K; Koh K; Shioda S; Iwasa S; Kashimoto K; Yajima T
Pharm Res; 2004 Jul; 21(7):1274-83. PubMed ID: 15290870
[TBL] [Abstract][Full Text] [Related]
12. Encapsulation of calcitonin in liposomes depends on the vesicle preparation method.
Arien A; Dupuy B
J Microencapsul; 1997; 14(6):753-60. PubMed ID: 9394256
[TBL] [Abstract][Full Text] [Related]
13. Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue.
Andreotti G; Vitale RM; Avidan-Shpalter C; Amodeo P; Gazit E; Motta A
J Biol Chem; 2011 Jan; 286(4):2707-18. PubMed ID: 21078667
[TBL] [Abstract][Full Text] [Related]
14. Acylation of salmon calcitonin modulates in vitro intestinal peptide flux through membrane permeability enhancement.
Trier S; Linderoth L; Bjerregaard S; Strauss HM; Rahbek UL; Andresen TL
Eur J Pharm Biopharm; 2015 Oct; 96():329-37. PubMed ID: 26347924
[TBL] [Abstract][Full Text] [Related]
15. NMR investigations of structural and dynamics features of natively unstructured drug peptide - salmon calcitonin: implication to rational design of potent sCT analogs.
Rawat A; Kumar D
J Pept Sci; 2013 Jan; 19(1):33-45. PubMed ID: 23208874
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of salmon calcitonin.
Meyer JP; Pelton JT; Hoflack J; Saudek V
Biopolymers; 1991 Feb; 31(2):233-41. PubMed ID: 2043752
[TBL] [Abstract][Full Text] [Related]
17. Solution structure and biological activity of recombinant salmon calcitonin S-sulfonated analog.
Wang Y; Dou H; Cao C; Zhang N; Ma J; Mao J; Wu H
Biochem Biophys Res Commun; 2003 Jun; 306(2):582-9. PubMed ID: 12804605
[TBL] [Abstract][Full Text] [Related]
18. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
19. Structural studies of EDTA-induced fibrillation of salmon calcitonin.
Seyferth S; Lee G
Pharm Res; 2003 Jan; 20(1):73-80. PubMed ID: 12608539
[TBL] [Abstract][Full Text] [Related]
20. The Interaction between Amyloid Prefibrillar Oligomers of Salmon Calcitonin and a Lipid-Raft Model: Molecular Mechanisms Leading to Membrane Damage, Ca
Diociaiuti M; Bombelli C; Zanetti-Polzi L; Belfiore M; Fioravanti R; Macchia G; Giordani C
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
